Literature DB >> 28784767

Identification of the Tau phosphorylation pattern that drives its aggregation.

Clément Despres1, Cillian Byrne2,3, Haoling Qi1, François-Xavier Cantrelle1, Isabelle Huvent1, Béatrice Chambraud4, Etienne-Emile Baulieu5, Yves Jacquot2, Isabelle Landrieu1, Guy Lippens6, Caroline Smet-Nocca7.   

Abstract

Determining the functional relationship between Tau phosphorylation and aggregation has proven a challenge owing to the multiple potential phosphorylation sites and their clustering in the Tau sequence. We use here in vitro kinase assays combined with NMR spectroscopy as an analytical tool to generate well-characterized phosphorylated Tau samples and show that the combined phosphorylation at the Ser202/Thr205/Ser208 sites, together with absence of phosphorylation at the Ser262 site, yields a Tau sample that readily forms fibers, as observed by thioflavin T fluorescence and electron microscopy. On the basis of conformational analysis of synthetic phosphorylated peptides, we show that aggregation of the samples correlates with destabilization of the turn-like structure defined by phosphorylation of Ser202/Thr205.

Entities:  

Keywords:  Alzheimer’s disease; NMR; Tau; aggregation; phosphorylation

Mesh:

Substances:

Year:  2017        PMID: 28784767      PMCID: PMC5576827          DOI: 10.1073/pnas.1708448114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  The repeat region of microtubule-associated protein tau forms part of the core of the paired helical filament of Alzheimer's disease.

Authors:  T Crowther; M Goedert; C M Wischik
Journal:  Ann Med       Date:  1989       Impact factor: 4.709

2.  A Phosphorylation-Induced Turn Defines the Alzheimer's Disease AT8 Antibody Epitope on the Tau Protein.

Authors:  Neha S Gandhi; Isabelle Landrieu; Cillian Byrne; Predrag Kukic; Laziza Amniai; François-Xavier Cantrelle; Jean-Michel Wieruszeski; Ricardo L Mancera; Yves Jacquot; Guy Lippens
Journal:  Angew Chem Int Ed Engl       Date:  2015-04-16       Impact factor: 15.336

3.  Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.

Authors:  Caroline Smet-Nocca; Malgorzata Broncel; Jean-Michel Wieruszeski; Caroline Tokarski; Xavier Hanoulle; Arnaud Leroy; Isabelle Landrieu; Christian Rolando; Guy Lippens; Christian P R Hackenberger
Journal:  Mol Biosyst       Date:  2011-02-16

4.  Tau polymerization: role of the amino terminus.

Authors:  T Chris Gamblin; Robert W Berry; Lester I Binder
Journal:  Biochemistry       Date:  2003-02-25       Impact factor: 3.162

Review 5.  Tau-aggregation inhibitor therapy for Alzheimer's disease.

Authors:  Claude M Wischik; Charles R Harrington; John M D Storey
Journal:  Biochem Pharmacol       Date:  2013-12-19       Impact factor: 5.858

Review 6.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.

Authors:  Diane P Hanger; Brian H Anderton; Wendy Noble
Journal:  Trends Mol Med       Date:  2009-02-24       Impact factor: 11.951

Review 7.  Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.

Authors:  Kurt R Brunden; Carlo Ballatore; Alex Crowe; Amos B Smith; Virginia M-Y Lee; John Q Trojanowski
Journal:  Exp Neurol       Date:  2009-09-08       Impact factor: 5.330

8.  C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease.

Authors:  A Abraha; N Ghoshal; T C Gamblin; V Cryns; R W Berry; J Kuret; L I Binder
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

Review 9.  A century of Alzheimer's disease.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  65 in total

1.  Tau Interacts with the C-Terminal Region of α-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations.

Authors:  Anvesh K R Dasari; Rakez Kayed; Sungsool Wi; Kwang Hun Lim
Journal:  Biochemistry       Date:  2019-06-07       Impact factor: 3.162

2.  Driving tau into phase-separated liquid droplets.

Authors:  Martin Margittai
Journal:  J Biol Chem       Date:  2019-07-19       Impact factor: 5.157

Review 3.  The structure and phase of tau: from monomer to amyloid filament.

Authors:  Yifan Zeng; Jing Yang; Bailing Zhang; Meng Gao; Zhengding Su; Yongqi Huang
Journal:  Cell Mol Life Sci       Date:  2020-10-19       Impact factor: 9.261

4.  A Mouse Model of Repetitive Blast Traumatic Brain Injury Reveals Post-Trauma Seizures and Increased Neuronal Excitability.

Authors:  Vladislav Bugay; Eda Bozdemir; Fabio A Vigil; Sang H Chun; Deborah M Holstein; William R Elliott; Cassie J Sprague; Jose E Cavazos; David O Zamora; Gregory Rule; Mark S Shapiro; James D Lechleiter; Robert Brenner
Journal:  J Neurotrauma       Date:  2019-10-21       Impact factor: 5.269

5.  Compound screening in cell-based models of tau inclusion formation: Comparison of primary neuron and HEK293 cell assays.

Authors:  Alex Crowe; Mark J Henderson; Johnathon Anderson; Steven A Titus; Alexey Zakharov; Anton Simeonov; Arjan Buist; Charlotte Delay; Diederik Moechars; John Q Trojanowski; Virginia M-Y Lee; Kurt R Brunden
Journal:  J Biol Chem       Date:  2020-02-07       Impact factor: 5.157

6.  Sleep Deprivation Affects Tau Phosphorylation in Human Cerebrospinal Fluid.

Authors:  Nicolas R Barthélemy; Haiyan Liu; William Lu; Paul T Kotzbauer; Randall J Bateman; Brendan P Lucey
Journal:  Ann Neurol       Date:  2020-02-27       Impact factor: 10.422

7.  Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer's Disease.

Authors:  Carol J Huseby; Claire N Hoffman; Grace L Cooper; Jean-Christophe Cocuron; Ana P Alonso; Stefani N Thomas; Austin J Yang; Jeff Kuret
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 8.  Elucidating Tau function and dysfunction in the era of cryo-EM.

Authors:  Guy Lippens; Benoît Gigant
Journal:  J Biol Chem       Date:  2019-05-14       Impact factor: 5.157

Review 9.  Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer's disease.

Authors:  Jangampalli Adi Pradeepkiran; Arubala P Reddy; P Hemachandra Reddy
Journal:  Drug Discov Today       Date:  2018-11-16       Impact factor: 7.851

Review 10.  Alzheimer's disease: phenotypic approaches using disease models and the targeting of tau protein.

Authors:  Elisabetta Lauretti; Domenico Praticò
Journal:  Expert Opin Ther Targets       Date:  2020-03-06       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.